Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson's disease. (January 2018)

• Record Type: Journal Article
• Authors: Jankovic, J.; Goodman, I.; Safirstein, B.; Schenk, D.B.; Kinney, G.G.; Koller, M.; Ness, D.K.; Griffith, S.G.; Grundman, M.; Soto, J.; Ostrowitzki, S.; Boess, F.G.; Martin-Facklam, M.; Quinn, J.F.; Issacson, S.H.; Jennings, D.; Omidvar, O.; Ellenbogen, A.
• Is Part Of: Parkinsonism & related disorders. Volume 46(2018)Supplement 2
• Page Start: e25
• Publication Date: 2018-01
• Subjects: Parkinson's disease -- Periodicals; Movement disorders -- Periodicals; Movement Disorders -- Periodicals; Nerve Degeneration -- Periodicals; Nervous System Diseases -- Periodicals; Parkinson Disease -- Periodicals; Tremor -- Periodicals; Parkinson, Maladie de -- Périodiques; Parkinson's disease; 616.833
• DOI: 10.1016/j.parkreldis.2017.11.083
• Languages: English
• ISSNs: 1353-8020